Chief Financial Officer
Chief Financial Officer at Spyre Therapeutics, Inc., filing insider transactions between 2026-03-03 and 2026-07-01.
| SEC ↗ |
| 2026-06-25 | SYRE | Sale | 10.0K | $87.14 | $871K | SEC ↗ |
| 2026-06-01 | SYRE | Sale | 3,100 | $72.06 | $223K | SEC ↗ |
| 2026-06-01 | SYRE | Sale | 1,801 | $69.75 | $126K | SEC ↗ |
| 2026-06-01 | SYRE | Sale | 2,599 | $70.77 | $184K | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 12.5K | $71.37 | $892K | SEC ↗ |
| 2026-04-01 | SYRE | Sale | 1,300 | $49.98 | $65K | SEC ↗ |
| 2026-04-01 | SYRE | Sale | 6,200 | $49.21 | $305K | SEC ↗ |
| 2026-03-03 | SYRE | Sale | 200 | $41.66 | $8K | SEC ↗ |
| 2026-03-03 | SYRE | Sale | 2,300 | $40.56 | $93K | SEC ↗ |